HYPD Stock Analysis: Buy, Sell, or Hold?
HYPD - Hyperion DeFi, Inc. Common Stock
$2.97
-0.12 (-3.88%)
▼
5d:
-8.9%
30d:
+17.86%
90d:
-18.18%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 12, 2026
28d
Get Alerted When HYPD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HYPD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: HYPD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.86
Based on -20.5% avg growth
INTRINSIC VALUE TODAY
$0.53
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HYPD is currently trading at $2.97, which is considered fair relative to its 30-day fair value range of $2.79 to $3.39. The stock's valuation (Forward PE: 6.8) is in line with its historical norms (7.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HYPD is showing sideways momentum. Immediate support is located at $2.56, while resistance sits at $4.05. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: HYPD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.95 (+134.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HYPD is showing sideways momentum. Immediate support is located at $2.56, while resistance sits at $4.05. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: HYPD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.95 (+134.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.79 -
$3.39
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
45.2%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 134.0% below Wall St target ($6.95)
- CAUTION: 5-day price weakness (-8.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.79 -
$3.39
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$4.05
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.83
Wall Street Target
$6.95
(+134.0%)
Revenue Growth (YoY)
1559.5%
Valuation Discount vs History
-0.6% cheaper
PE vs Historical
6.8 vs 7.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.6%
(market-implied from PE analysis)
1-Year Target
$2.95
(-1%)
2-Year Target
$2.93
(-1%)
3-Year Target
$2.92
(-2%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
$2.99
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -44.9%)
$6.91
(+133%)
Base:
(SPY PE: 6.8, Growth: -44.9%)
$2.17
(-27%)
Bear:
(PE: 5.8, Growth: -44.9%)
$1.84
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.8 to 7.0
Stabilization Target:
$3.04
(+2.5%)
PE Expansion Potential:
+2.5%
Share & Embed Analysis
Last updated: July 14, 2026 2:09 AM ET
Data refreshes hourly during market hours. Next update: 3:09 AM
Data refreshes hourly during market hours. Next update: 3:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 60 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 62 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 67 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
